Acasti Pharma Inc

For the period ended Mar 31, 2024. Filed Jun 21, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Jun 21, 2024

GRCE$1.85+3.9%Stored close · as of Nov 6, 2026

Opening this filing…